US20150034872A1 - Liquid crystals comprising cyclopentane groups - Google Patents

Liquid crystals comprising cyclopentane groups Download PDF

Info

Publication number
US20150034872A1
US20150034872A1 US14/456,743 US201414456743A US2015034872A1 US 20150034872 A1 US20150034872 A1 US 20150034872A1 US 201414456743 A US201414456743 A US 201414456743A US 2015034872 A1 US2015034872 A1 US 2015034872A1
Authority
US
United States
Prior art keywords
compound
ocf
mixture
formula
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/456,743
Inventor
Xinhua Chen
R. Amaranatha Reddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VVI Bright China Ltd
Original Assignee
VVI Bright China Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VVI Bright China Ltd filed Critical VVI Bright China Ltd
Priority to US14/456,743 priority Critical patent/US20150034872A1/en
Publication of US20150034872A1 publication Critical patent/US20150034872A1/en
Priority to US14/882,283 priority patent/US9822303B2/en
Assigned to VVI BRIGHT, INC. reassignment VVI BRIGHT, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHEN, XINHUA, REDDY, R. AMARANATHA
Assigned to VVI BRIGHT CHINA LTD reassignment VVI BRIGHT CHINA LTD ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: VVI BRIGHT, INC.
Priority to US15/817,634 priority patent/US10745617B2/en
Priority to US16/993,934 priority patent/US20210122978A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/32Non-steroidal liquid crystal compounds containing condensed ring systems, i.e. fused, bridged or spiro ring systems
    • C09K19/322Compounds containing a naphthalene ring or a completely or partially hydrogenated naphthalene ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C25/00Compounds containing at least one halogen atom bound to a six-membered aromatic ring
    • C07C25/18Polycyclic aromatic halogenated hydrocarbons
    • C07C25/22Polycyclic aromatic halogenated hydrocarbons with condensed rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K19/3405Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a five-membered ring
    • C07C2101/08
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K19/3405Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a five-membered ring
    • C09K2019/3408Five-membered ring with oxygen(s) in fused, bridged or spiro ring systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2323/00Functional layers of liquid crystal optical display excluding electroactive liquid crystal layer characterised by chemical composition

Definitions

  • Liquid crystal displays use mixtures of liquid crystals having desired material properties such as operating temperature range, thermal stability, light stability, switching time, and contrast ratio.
  • the properties of the mixtures and devices are determined by the constituents of the mixtures.
  • liquid crystal displays having improved performance has increased.
  • liquid crystal mixtures having low threshold voltage are desired, especially for display applications.
  • the threshold voltage is the amount of voltage needed to apply across a pixel to produce a response. Addressing pixels with lower voltages allows simplification of the electronics used, resulting in the possibility for space and weight savings.
  • the threshold voltage is inversely proportional to the dielectric anisotropy of the mixture. Therefore, one way to produce a liquid crystal mixture having a low threshold voltage is the use of mixtures having a large (positive or negative) dielectric constant.
  • liquid crystal compounds and mixtures incorporating the same generally comprise a cyclopentane group and at least two other rings.
  • the liquid crystal compounds of the invention comprise a cyclopentane group and at least two other rings, one of which is a fused ring system.
  • the liquid crystal compounds of the invention comprise a terminal cyclopentane group and at least two other rings, one of which is a fused ring system. More specifically, compounds of the invention have general Formula I:
  • R is selected from the group consisting of H and unsubstituted or substituted alkyl each having 1-12 carbon atoms wherein the substitutions are independently one or more of halogen or —CN, wherein one or more —CH 2 — groups of the alkyl groups may independently be replaced with —O—, —S—, —CO—, —CO—O—, —O—CO—, —O—CO—O— or —CH ⁇ CH—, provided that heteroatoms are not connected directly, except as permitted in the listed groups;
  • a and B are each independently selected from the group consisting of: 1,4-cyclohexylene, in which one —CH 2 — or two not directly linked —CH 2 — can be replaced by —O— or —S—; 1,4-cyclohexenylene; piperidine-1,4-diyl; 1,4-bicyclo[2,2,2]octylene; 1,4-phenyl; pyridin-5,2-diyl
  • X 1 , X 2 , X 3 , and X 4 are each independently selected from the group consisting of: —H, —F, —Cl, —CF 3 , —CHF 2 and —CN.
  • any group for example a ring structure, may be attached in any suitable location. If there are two or more rings linked together, for example, when n, m or k is not 0, it is noted that each of the rings may be the same of different. As an example of this, when n is 2, the two “A” rings do not need to be the same, although they may be in certain embodiments.
  • indane means:
  • indene means:
  • indane and indene groups When linked as an A or B ring, the indane and indene groups are called indanediyl and indenediyl groups.
  • a “single bond” as a variable means that there is a direct linkage between two structures. For example, if Z 1 is a single bond and n is 1, there is a direct linkage between the cyclopentane ring and the A ring.
  • a “fused ring system” has at least two rings joined together at at least two atoms.
  • halogen means fluorine, chlorine, bromine or iodine.
  • a compound of the invention is one of I-11 through I-17. In one embodiment, a compound of the invention is one of I-23 through I-27. In one embodiment, a compound of the invention is one of I-33 through I-35. In an embodiment, a compound of the invention is one of I-36 through I-47. In one embodiment, a compound of the invention has R ⁇ H and a fused ring system.
  • one or more hydrogen atoms on one or more rings is replaced with deuterium. In an embodiment, one or more hydrogen atoms on a non-ring structure is replaced with deuterium.
  • the cyclopentene ring has one of the structures below:
  • Devices comprising one or more compounds of the invention can be made and operated by one of ordinary skill in the art without undue experimentation.
  • the compounds of the invention have a high dielectric constant which may be positive or negative.
  • the use of compounds and mixtures having negative or positive dielectric constants is known in the art.
  • the compounds have positive dielectric constant of at least 8.
  • the compounds have a negative dielectric constant of ⁇ 2 or less. Larger positive and larger negative numbers are desired.
  • Y is independently selected from the group consisting of —F, —Cl, —CF 3 , —OCF 3 , —OCHF 2 , —OCF 2 CF 3 , —OCF ⁇ CF 2 , —OCHFCF 3 , —OCF 2 CF ⁇ CF 2 ;
  • X 1 , X 2 , X 3 , X 4 are each, independently of one another, —H or —F;
  • Z is independently selected from the group consisting of: single bond, —C 2 H 4 —, —CF 2 O—, —CF ⁇ CF—, —C 2 F 4 —, —CO 2 —, —C 4 H 8 —, —C 2 H 4 CF 2 O—, —OCF 2 CF 2 O—, —CH ⁇ CHCH 2 CH 2 —, —CH 2 CH 2 CH ⁇ CH—; and R is C1-C12 alkyl or H.
  • R is —H or C1-C7 n-alkyl; R′ is C1-C7 n-alkyl or C1-C7 alkoxy;
  • X 1 and X 2 are each independently selected from the group consisting of —F, —Cl, —CF 3 , —CHF 2 , —OCF 3 and —OCF 2 H;
  • X 3 , X 4 , X 5 and X 6 are each independently —H or —F;
  • Z is independently single bond, —C 2 H 4 —, —C 4 H 8 —, —CF 2 O—, —CF ⁇ CF—, —C 2 F 4 —, —C 2 H 4 CF 2 O— or —CO 2 —.
  • liquid crystal mixtures As known in the art, there are typically many components of liquid crystal mixtures, as determined by the desired use of the mixture.
  • the composition of the liquid crystal mixtures of the invention can be determined by one having ordinary skill in the art without undue experimentation.
  • the addition of one or more compounds of the invention in liquid crystal mixtures improves the properties of the mixture, including lowering threshold voltage, increasing switching speed and other properties which are known in the art.
  • the compounds of the invention may be used as components in any desired liquid crystal mixture, such as those mixtures known in the art.
  • the liquid crystal mixture comprises one or more compounds of Formula I.
  • the liquid crystal mixture has positive dielectric constant.
  • the liquid crystal mixture having positive dielectric constant comprises one or more compounds of Formula I-1 through I-17.
  • the mixture may include one or more compounds of Formula I and one or more compounds of Formula II-XVI:
  • R is C1-C9 n-alkyl, C1-C9 alkoxy, C1-C9 oxaalkyl, C1-C9 fluoroalkyl or C1-C9 alkenyl;
  • X is —F, —Cl, halogenated C1-C6 alkyl, halogenated C1-C6 alkenyl, halogenated C1-6 alkenyloxy or halogenated C1-C6 alkoxy;
  • Z is —C 2 H 4 —, —C 4 H 8 —, —CH ⁇ CH—, —CH 2 O—, —COO—, —OCH 2 —, —OCF 2 —, —CF 2 O—, —CF ⁇ CF—, —C 2 F 4 —, —CH 2 CF 2 — or —CF 2 CH 2 —;
  • Y 1 , Y 2 , Y 3 and Y 4 are each, independently of one another
  • the mixture may comprise one or more compounds of Formula I and one or more compounds selected from the group consisting of compounds of the structure below XVII-XXIII.
  • R 1 and R 2 are each independently C1-C9 n-alkyl, C1-C9 alkoxy, C1-C9 oxaalkyl, or C1-C9 alkenyl; Y 1 , Y 2 , Y 3 and Y 4 are each, independently of one another, —H or —F, and r is 0, 1 or 2.
  • R is C1-C8 n-alkyl, C1-C8 alkoxy, C1-C8 alkenyl or C1-C8 alkenyloxy;
  • R′ is C1-C8 alkyl, C1-C8 alkoxy, C1-C8 alkenyl or C1-C8 alkenyloxy;
  • X 1 , X 2 , X 3 , X 4 , X 5 and X 6 are independently selected from the group consisting of: —H, —F, —Cl, —CHF 2 , —CF 3 , —OCF 3 and —OCHF 2 ; with the proviso that at least two from X 1 to X 6 are —F, —Cl, —CHF 2 or —CF 3 ;
  • Z is independently selected from the group consisting of: single bond, —C 2 H 4 —, —C 4 H 8 —, —CH ⁇ CHCH 2 CH 2 —, —CH
  • R 1 and R 2 are each independently C1-C8 n-alkyl, C1-C8 alkoxy, C1-C8 oxaalkyl, C1-8 alkenyl, or C1-C8 alkenyloxy;
  • X 1 , X 2 , X 3 , and X 4 are —H or —F, provided that only one of X 1 , X 2 , X 3 , and X 4 may be F in the same compound;
  • r is 1 or 2;
  • k is 1 or 2.
  • the compounds of the invention may be used in any useful amount in a liquid crystal mixture, including less than 0.1% by weight of the total composition; less than 0.5% by weight of the total composition; less than 1% by weight of the total composition, less than 3% by weight of the total composition; less than 5% by weight of the total composition; less than 7% by weight of the total composition; less than 10% by weight of the total composition; less than 20% by weight of the total composition; less than 25% by weight of the total composition; less than 30% by weight of the total composition; less than 35% by weight of the total composition; less than 40% by weight of the total composition; less than 50% by weight of the total composition; and any other useful amount.
  • Grignard reagent was prepared from 6-methoxy-2-bromonaphthalene, dry Mg, a crystal of iodine and a drop of 1,2-dibromoethane in dry THF. This mixture was then cooled in an ice-sodium chloride bath, a solution of dried cyclopentanone dry THF was added drop wise via syringe. The resultant reaction mixture was then slowly warmed to room temperature. Then refluxed for additional 10 hours and cooled to room temperature, added to ice cold HCl and extracted using ethyl acetate. The combined organic extracts were washed with sat. NH 4 Cl solution and dried over MgSO 4 . The crude product obtained was passed through a column of silicagel using 15% EA in hexane as eluent. Yield of the product: 70%.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Provided are liquid crystal compounds and mixtures incorporating the same. The liquid crystal compounds of the invention generally comprise a cyclopentane group and at least two other rings. In one embodiment, the liquid crystal compounds of the invention comprise a cyclopentane group and at least two other rings, one of which is a fused ring system.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. patent application Ser. No. 12/866,295, filed Aug. 5, 2010, which is the U.S. National Stage of International Application No. PCT/US2009/033197, filed Feb. 5, 2009, which claims the benefit of priority to U.S. Provisional Application Ser. No. 61/027,230, filed Feb. 8, 2008, each of which is hereby incorporated by reference to the extent not inconsistent with the disclosure herewith.
  • BACKGROUND OF THE INVENTION
  • Liquid crystal displays use mixtures of liquid crystals having desired material properties such as operating temperature range, thermal stability, light stability, switching time, and contrast ratio. The properties of the mixtures and devices are determined by the constituents of the mixtures.
  • The demand for liquid crystal displays having improved performance has increased. In particular, liquid crystal mixtures having low threshold voltage are desired, especially for display applications. The threshold voltage is the amount of voltage needed to apply across a pixel to produce a response. Addressing pixels with lower voltages allows simplification of the electronics used, resulting in the possibility for space and weight savings. The threshold voltage is inversely proportional to the dielectric anisotropy of the mixture. Therefore, one way to produce a liquid crystal mixture having a low threshold voltage is the use of mixtures having a large (positive or negative) dielectric constant.
  • U.S. Pat. No. 5,759,443, U.S. Pat. No. 4,873,019, CN 1928001A, and EP patent application EP0789067A1 disclose certain compounds having cyclopentyl groups.
  • There is a continuing need in the art for improved liquid crystal compounds and mixtures.
  • BRIEF SUMMARY OF THE INVENTION
  • Provided are liquid crystal compounds and mixtures incorporating the same. The liquid crystal compounds of the invention generally comprise a cyclopentane group and at least two other rings. In one embodiment, the liquid crystal compounds of the invention comprise a cyclopentane group and at least two other rings, one of which is a fused ring system. In one embodiment, the liquid crystal compounds of the invention comprise a terminal cyclopentane group and at least two other rings, one of which is a fused ring system. More specifically, compounds of the invention have general Formula I:
  • Figure US20150034872A1-20150205-C00001
  • wherein
    R is selected from the group consisting of H and unsubstituted or substituted alkyl each having 1-12 carbon atoms wherein the substitutions are independently one or more of halogen or —CN, wherein one or more —CH2— groups of the alkyl groups may independently be replaced with —O—, —S—, —CO—, —CO—O—, —O—CO—, —O—CO—O— or —CH═CH—, provided that heteroatoms are not connected directly, except as permitted in the listed groups;
    A and B are each independently selected from the group consisting of: 1,4-cyclohexylene, in which one —CH2— or two not directly linked —CH2— can be replaced by —O— or —S—; 1,4-cyclohexenylene; piperidine-1,4-diyl; 1,4-bicyclo[2,2,2]octylene; 1,4-phenyl; pyridin-5,2-diyl; pyrimidin-5,2-diyl; naphthalene-2,6-diyl; trans-decahydronaphthalene-2,6-diyl; tetrahydronaphthalene-2,6-diyl; indenediyl; indenediyl; phenanthrenediyl; and dibenzofurandiyl, which may each independently in each instance be substituted with one or more halogens and/or one or more X1-X4 substituents;
    Z1 is a single bond or C1-C7 unsubstituted or substituted alkylene, wherein the substitutions are independently one or more of halogen or —CN, wherein one or more —CH2— groups of the alkyl groups may each independently be replaced by —O—, —S—, —CO—O—, —O—CO—, —O—CO—O— or —CH═CH— provided that heteroatoms are not connected directly to each other except as permitted in the listed groups;
    Z2 and Z3 are each independently selected from the group consisting of: a single bond, —(CH2)2—, —(CH2)4—, —CH═CHCH2CH2—, —CH2CH2CH═CH—, —CF2O—, —OCF2-, —CF2CF2—, —CF═CF—, —CH2CF2—, —CF2CH2—, —OCF2CF2O—, —C2H4CF2O—, —CH2CF2OCH2—, —CH2OCF2CH2—, —OCF2C2H4—, —C3H6O—, —CO3H6—, —C2H4OCH2—, —CH2OC2H4—, —CH2O—, —OCH2—, —CH═CH—, and —COO—;
    n, m and K are each independently 0, 1, or 2, and m+K+n≧2;
    X1, X2, X3, and X4 are each independently selected from the group consisting of: —H, —F, —Cl, —CF3, —CHF2, —OCF3, —OCF2H and —CN;
    Y is independently selected from the group consisting of: —H, —F, —Cl, —CN, —NCS, —OCHF2, —CHF2, —OCF3, —OCF2CF3, —CF3, C1-20 alkyl, C1-20 alkoxy, C1-20 alkenyl, and C1-20 alkenyloxy, wherein the alkyl, alkoxy, alkenyl, and alkenyloxy groups may be independently substituted by one or more halogens;
    wherein one or more hydrogen atoms in Formula I may be replaced with deuterium;
    provided that when R═H and Y has less than 2 carbon atoms and X3, X4 are H or when R═H and Y has two or more carbon atoms and Z1 has more than 3 carbon atoms, there must be a fused ring system present in the compound or one of Z1, Z2 and Z3 must be selected from the group consisting of: C1-C3 alkylene, —CH═CHCH2CH2—, —CH2CH2CH═CH—CF2O—, —OCF2—, —CF2CF2—, —CF═CF—, —CH2CF2—, —CF2CH2—, —OCF2CF2O—, —C2H4CF2O—, —CH2CF2OCH2-, —CH2OCF2CH2-, —OCF2C2H4—, —C3H6O—, —OC3H6—, —C2H4OCH2—, —CH2OC2H4—, and —CH═CH—;
    and provided that when R is not H and Y does not contain a —CF2— group, either one of A and B is selected from the group consisting of: 1,4-cyclohexylene, in which one or two not directly linked —CH2— groups can be replaced by —O— or —S—; pyridin-5,2-diyl; pyrimidin-5,2-diyl; indanediyl; indenediyl; phenanthrenediyl; and dibenzofurandiyl; or
    one of Z1, Z2 and Z3 must be selected from the group consisting of: —(CH2)4—, —CH═CHCH2CH2—, —CH2CH2CH═CH—, —CF2O—, —OCF2—, —CF2CF2—, —CF═CF—, —CH2CF2—, —CF2CH2—, —OCF2CF2O—, —C2H4CF2O—, —CH2CF2OCH2—, —CH2OCF2CH2—, —OCF2C2H4—, —C3H6O—, —CO3H6—, —C2H4OCH2—, —CH2OC2H4—, —CH═CH—, and —C≡C—.
  • In an embodiment, X1, X2, X3, and X4 are each independently selected from the group consisting of: —H, —F, —Cl, —CF3, —CHF2 and —CN.
  • If not specified, any group, for example a ring structure, may be attached in any suitable location. If there are two or more rings linked together, for example, when n, m or k is not 0, it is noted that each of the rings may be the same of different. As an example of this, when n is 2, the two “A” rings do not need to be the same, although they may be in certain embodiments. When used herein, “indane” means:
  • Figure US20150034872A1-20150205-C00002
  • which is attached to the remainder of the structure in any suitable location(s). When used herein, “indene” means:
  • Figure US20150034872A1-20150205-C00003
  • which is attached to the remainder of the structure in any suitable location(s). When linked as an A or B ring, the indane and indene groups are called indanediyl and indenediyl groups.
  • As used herein, a “single bond” as a variable means that there is a direct linkage between two structures. For example, if Z1 is a single bond and n is 1, there is a direct linkage between the cyclopentane ring and the A ring. As used herein, a “fused ring system” has at least two rings joined together at at least two atoms. 1,4-bicyclo[2.2.2]octylene; naphthalene-2,6-diyl; decahydronaphthalene-2,6-diyl; tetrahydronaphthalene-2,6-diyl; indanediyl; indenediyl; phenanthrenediyl; and dibenzofurandiyl are all examples of fused ring systems. As used herein, halogen means fluorine, chlorine, bromine or iodine.
  • In one embodiment, there is at least one fused ring in a compound of the invention. In one embodiment, a compound of the invention is one of I-11 through I-17. In one embodiment, a compound of the invention is one of I-23 through I-27. In one embodiment, a compound of the invention is one of I-33 through I-35. In an embodiment, a compound of the invention is one of I-36 through I-47. In one embodiment, a compound of the invention has R═H and a fused ring system.
  • In an embodiment, one or more hydrogen atoms on one or more rings is replaced with deuterium. In an embodiment, one or more hydrogen atoms on a non-ring structure is replaced with deuterium.
  • In separate embodiments, the cyclopentene ring has one of the structures below:
  • Figure US20150034872A1-20150205-C00004
  • All possible locations of one or more deuterium substitution for hydrogen in the structures shown and described herein are intended to be included to the same extent as if they were individually shown.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The following non-limiting description provides examples of some embodiments of the invention.
  • The use of one or more compounds of the invention in mixtures having desired properties for various liquid crystal applications is known to one of ordinary skill in the art without undue experimentation.
  • Devices comprising one or more compounds of the invention can be made and operated by one of ordinary skill in the art without undue experimentation.
  • The description herein provides some additional exemplary embodiments of the invention and variables which can be separate or combined together in all possible permutations, independently and in combination, to formulate compounds of the invention.
  • The compounds of the invention have a high dielectric constant which may be positive or negative. The use of compounds and mixtures having negative or positive dielectric constants is known in the art. In some embodiments of the invention, the compounds have positive dielectric constant of at least 8. In some embodiments of the invention, the compounds have a negative dielectric constant of −2 or less. Larger positive and larger negative numbers are desired.
  • Positive Dielectric Constant Compounds
  • Specific particular embodiments of compounds of the invention having positive dielectric constants are shown below in structures I-1 through I-17, where the variables have the following definitions:
  • Y is independently selected from the group consisting of —F, —Cl, —CF3, —OCF3, —OCHF2, —OCF2CF3, —OCF═CF2, —OCHFCF3, —OCF2CF═CF2;
    X1, X2, X3, X4 are each, independently of one another, —H or —F;
    Z is independently selected from the group consisting of: single bond, —C2H4—, —CF2O—, —CF═CF—, —C2F4—, —CO2—, —C4H8—, —C2H4CF2O—, —OCF2CF2O—, —CH═CHCH2CH2—, —CH2CH2CH═CH—; and R is C1-C12 alkyl or H.
  • Figure US20150034872A1-20150205-C00005
    Figure US20150034872A1-20150205-C00006
    Figure US20150034872A1-20150205-C00007
  • Negative Dielectric Constant Compounds
  • Specific particular embodiments of compounds of the invention having positive dielectric constants are shown below in structures I-18 through I-47, where the variables have the following definitions:
  • R is —H or C1-C7 n-alkyl;
    R′ is C1-C7 n-alkyl or C1-C7 alkoxy;
    X1 and X2 are each independently selected from the group consisting of —F, —Cl, —CF3, —CHF2, —OCF3 and —OCF2H;
    X3, X4, X5 and X6 are each independently —H or —F;
    Z is independently single bond, —C2H4—, —C4H8—, —CF2O—, —CF═CF—, —C2F4—, —C2H4CF2O— or —CO2—.
  • Figure US20150034872A1-20150205-C00008
    Figure US20150034872A1-20150205-C00009
    Figure US20150034872A1-20150205-C00010
    Figure US20150034872A1-20150205-C00011
  • Mixtures
  • As known in the art, there are typically many components of liquid crystal mixtures, as determined by the desired use of the mixture. The composition of the liquid crystal mixtures of the invention can be determined by one having ordinary skill in the art without undue experimentation. The addition of one or more compounds of the invention in liquid crystal mixtures improves the properties of the mixture, including lowering threshold voltage, increasing switching speed and other properties which are known in the art.
  • Positive Dielectric Constant Mixture
  • The compounds of the invention may be used as components in any desired liquid crystal mixture, such as those mixtures known in the art. In one embodiment, the liquid crystal mixture comprises one or more compounds of Formula I. In one embodiment, the liquid crystal mixture has positive dielectric constant. In one embodiment, the liquid crystal mixture having positive dielectric constant comprises one or more compounds of Formula I-1 through I-17.
  • The mixture may include one or more compounds of Formula I and one or more compounds of Formula II-XVI:
  • Figure US20150034872A1-20150205-C00012
    Figure US20150034872A1-20150205-C00013
  • in which the individual variables have the following definitions:
    R is C1-C9 n-alkyl, C1-C9 alkoxy, C1-C9 oxaalkyl, C1-C9 fluoroalkyl or C1-C9 alkenyl;
    X is —F, —Cl, halogenated C1-C6 alkyl, halogenated C1-C6 alkenyl, halogenated C1-6 alkenyloxy or halogenated C1-C6 alkoxy;
    Z is —C2H4—, —C4H8—, —CH═CH—, —CH2O—, —COO—, —OCH2—, —OCF2—, —CF2O—, —CF═CF—, —C2F4—, —CH2CF2— or —CF2CH2—;
    Y1, Y2, Y3 and Y4 are each, independently of one another, —H or —F; and
    r is 0, 1 or 2; and k is 0 or 1, provided that if both r and k appear in the same formula, r+k≧2.
  • Additional specific examples of compounds which may be included in a mixture are shown below where R is as defined for compounds II-XVI:
  • Figure US20150034872A1-20150205-C00014
    Figure US20150034872A1-20150205-C00015
  • In each of the formulas shown herein, the structure:
  • Figure US20150034872A1-20150205-C00016
  • may have any of the following formulas:
  • Figure US20150034872A1-20150205-C00017
  • In other embodiments, the mixture may comprise one or more compounds of Formula I and one or more compounds selected from the group consisting of compounds of the structure below XVII-XXIII.
  • Figure US20150034872A1-20150205-C00018
  • where the variables have the following definitions:
    R1 and R2 are each independently C1-C9 n-alkyl, C1-C9 alkoxy, C1-C9 oxaalkyl, or C1-C9 alkenyl;
    Y1, Y2, Y3 and Y4 are each, independently of one another, —H or —F, and
    r is 0, 1 or 2.
  • Negative Dielectric Constant Mixtures
  • In one embodiment, the liquid crystal mixture has negative dielectric constant. In one embodiment, the liquid crystal mixture having negative dielectric constant comprises one or more compound of Formula I-18 through I-47. In another embodiment, the liquid crystal mixture having negative dielectric constant comprises one or more compounds of Formula I, such as I-18 to I-47 and additionally comprises a useful amount of one or more compounds selected from the group consisting of compounds of the general formulae XXIV to XLIV, where the variables are as defined below:
  • R is C1-C8 n-alkyl, C1-C8 alkoxy, C1-C8 alkenyl or C1-C8 alkenyloxy;
    R′ is C1-C8 alkyl, C1-C8 alkoxy, C1-C8 alkenyl or C1-C8 alkenyloxy;
    X1, X2, X3, X4, X5 and X6 are independently selected from the group consisting of: —H, —F, —Cl, —CHF2, —CF3, —OCF3 and —OCHF2; with the proviso that at least two from X1 to X6 are —F, —Cl, —CHF2 or —CF3;
    Z is independently selected from the group consisting of: single bond, —C2H4—, —C4H8—, —CH═CHCH2CH2—, —CH2CH2CH═CH—, —CF2O—, —OCF2—, —CF═CF—, —C2F4—, —C2H4CF2O—, —OCF2C2H4— and —CO2—;
    r is 0, 1 or 2; k is 0 or 1, providing that r+k≧2.
  • Figure US20150034872A1-20150205-C00019
    Figure US20150034872A1-20150205-C00020
    Figure US20150034872A1-20150205-C00021
  • In other specific embodiments, the negative dielectric constant mixture may comprise one or more compounds of Formula I and one or more compounds selected from the group consisting of compounds of formulas XLV-XLVIII below.
  • Figure US20150034872A1-20150205-C00022
  • in which the individual variables have the following definitions:
    R1 and R2 are each independently C1-C8 n-alkyl, C1-C8 alkoxy, C1-C8 oxaalkyl, C1-8 alkenyl, or C1-C8 alkenyloxy;
    X1, X2, X3, and X4 are —H or —F, provided that only one of X1, X2, X3, and X4 may be F in the same compound;
    r is 1 or 2; k is 1 or 2.
  • The compounds of the invention may be used in any useful amount in a liquid crystal mixture, including less than 0.1% by weight of the total composition; less than 0.5% by weight of the total composition; less than 1% by weight of the total composition, less than 3% by weight of the total composition; less than 5% by weight of the total composition; less than 7% by weight of the total composition; less than 10% by weight of the total composition; less than 20% by weight of the total composition; less than 25% by weight of the total composition; less than 30% by weight of the total composition; less than 35% by weight of the total composition; less than 40% by weight of the total composition; less than 50% by weight of the total composition; and any other useful amount.
  • In one embodiment, there is between 0.5% and 80% of one or more compounds of Formula I. In one embodiment, there is between 0.5% and 80% of one or more compounds of Formula I-1 through I-17. In one embodiment, there is between 0.5% and 80% of one or more compounds of Formula I-18 through I-35. In one embodiment, there is between 0.5% and 80% of one or more compounds of Formula I, and between 0.5% and 80% or one or more compounds of a compound of formula II-XVI In one embodiment, there is between 0.5% and 80% of one or more compounds of Formula I, and between 0.5% and 80% of one or more compounds of Formula XVII-XXIII. In one embodiment, there is between 0.5% and 80% of one or more compounds of Formula I, between 0.5% and 80% or one or more compounds of Formula II-XVI, and between 0.5% and 80% of one or more compounds of Formula XVII-XXIII. In one embodiment, there is between 0.5% and 80% of one or more compounds of Formula I, and between 0.5% and 80% or one or more compounds of a compound of formula XXIV-XLIV. In one embodiment, there is between 0.5% and 80% of one or more compounds of Formula I, and between 0.5% and 80% of one or more compounds of Formula XLV-XLVIII. In one embodiment, there is between 0.5% and 80% of one or more compounds of Formula I, between 0.5% and 80% or one or more compounds of Formula XXIV-XLIV, and between 0.5% and 80% of one or more compounds of Formula XLV-XLVIII. There may be other components, as known in the art.
  • Synthesis
  • The following describes exemplary synthesis reactions for compounds of the invention. Conditions for such as reaction are well-known to one of ordinary skill in the art. The synthesis of compounds of the invention not specifically exemplified here can be carried out by one of ordinary skill in the art without undue experimentation using methods known in the art.
  • Figure US20150034872A1-20150205-C00023
  • Experimental Synthesis of 2-Cyclopentyl-6-(3,4,5-trifluorophenyl)naphthalene Synthesis of 1-(6-methoxynaphthalene-2-yl)cyclopentanol (Compound 1)
  • Grignard reagent was prepared from 6-methoxy-2-bromonaphthalene, dry Mg, a crystal of iodine and a drop of 1,2-dibromoethane in dry THF. This mixture was then cooled in an ice-sodium chloride bath, a solution of dried cyclopentanone dry THF was added drop wise via syringe. The resultant reaction mixture was then slowly warmed to room temperature. Then refluxed for additional 10 hours and cooled to room temperature, added to ice cold HCl and extracted using ethyl acetate. The combined organic extracts were washed with sat. NH4Cl solution and dried over MgSO4. The crude product obtained was passed through a column of silicagel using 15% EA in hexane as eluent. Yield of the product: 70%.
  • 2-Cyclopentenyl-6-methoxynaphthalene (Compound 2)
  • A solution of compound 1 in dry benzene, and a catalytic amount (2 wt %) of p-toluene-sulfonic acid were placed in a round-bottomed flask. The resulting solution was then heated at 50° C. for 15 minutes, the reaction was complete, and the resulting solution was cooled to room temperature, passed through a short pad of silicagel. Yield was almost quantitative, the product obtained was pure enough which was directly used for the next reaction.
  • 2-Cyclopentyl-6-methoxynaphthalene (Compound 3)
  • To a solution of compound 2 in ethyl acetate was added a catalytic amount (5 wt %) of 5% Pd—C, the resulting solution was continued stirring vigorously until the reaction is complete. Yield was almost quantitative. The product obtained was pure enough, which was directly used for the next reaction.
  • 6-Cyclopentylnaphthalen-2-ol (Compound 4)
  • A solution of compound 3 in dry dichloromethane was cooled to −78° C. in dry ice and acetone under argon. To this with stirring, a solution of BBr3 in dichloromethane was added dropwise and the resulting solution was continued stirring for additional 2 hours at this temperature and allowed to warm to room temperature overnight. The resultant solution was extracted using ethyl acetate, the crude product was crystallized from a mixture of methanol and hexane. Yield: 92%.
  • 6-Cyclopentylnaphthalen-2-yl trifluoromethylsulfonate (Compound 5)
  • A solution of compound 4 and pyridine in dry dichloromethane was cooled to 5° C. using ice bath. To this with stirring, a solution of triflic anhydride in dichloromethane was added dropwise which was allowed to warm to room temperature, and continued stirring for additional 2 hours. The resultant solution was extracted using ethyl acetate, the product obtained was a low melting solid, which was directly used for the next step. Yield: 95%.
  • 2-Cyclopentyl-6-(3,4,5-trifluorophenyl)naphthalene (Compound 6)
  • Into a flame dried 100 ml round-bottomed flask with a magnetic stir bar, was charged with compound 5 (1.0 g, 2.9 mMol), 3,4,5-trifluorophenyl boronic acid (0.56 g, 3.19 mMol), 20 mL toluene, 2M K2CO3 (20 mL), Bu4NBr (25 mg) and the mixture flushed with argon for 10 min. [Pd(PPh3)4] (0.1 g) was added and the mixture heated under argon at ˜85° C. for 12 h, with vigorous stirring. After cooling to room temperature, 25 mL water was added, extracted with 3×10 mL ethyl acetate, the organic extracts dried over MgSO4, and the crude product was then passed through a column of silica gel using hexane as eluent, also crystallized from hexane. Yield, 0.89 g (94%).
  • Figure US20150034872A1-20150205-C00024
  • Synthesis of 2-(Cyclopentylethyl)-6-(3,4,5-trifluorophenyl)naphthalene 1. 6-(3,4,5-trifluorophenyl)naphthalene-2-ol (Compound 1)
  • A flame dried 500 ml round-bottomed flask with a magnetic stir bar, was charged with 6-hydroxy-2-bromonaphthalene (8.0 g, 35.89 mMol), 3,4,5-trifluorophenyl boronic acid (6.9 g, 39.5 mMol), 75 mL toluene, 2M K2CO3 (80 mL), Bu4NBr (50 mg) and the mixture flushed with argon for 10 min. [Pd(PPh3)4] (0.5 g) was added and the mixture heated under argon at ˜85° C. overnight, with vigorous stirring. After cooling to room temperature, 50 mL water was added, extracted with 3×25 mL ethyl acetate, the organic extracts dried over MgSO4, and the crude product was then crystallized from a mixture of hexane and few drops of methanol. Yield: 8 g (87%).
  • 6-(3,4,5-trifluorophenyl)naphthalene-2-yl trifluoromethylsulfonate (Compound 2)
  • A solution of compound 1 and pyridine in dry dichloromethane was cooled to 5C using ice bath. To this with stirring, a solution of triflic anhydride in dichloromethane was added drop wise which is allowed to warm to room temperature, and continued stirring for additional 2 hours. The resultant solution was extracted using ethyl acetate, the product obtained was crystallized from dichloromethane and hexane mixture. Yield: 90%.
  • 1-((6-(3,4,5-trifluorophenyl)naphthalen-2-yl)ethynyl)cyclopentanol (Compound 3)
  • To a solution of triflet (compound 2) and 1-ethynylcyclopentanol in dry DMF under argon, Pd(PPh3)4, CuI and triethylamine were successively added, and the reaction mixture was stirred overnight at room temperature. The mixture was then diluted with EtOAc, washed with water and dried over MgSO4. Yield: 93%.
  • 2-(Cyclopentylethynyl)-6-(3,4,5-trifluorophenyl)naphthalene (compound 4)
  • A solution of compound 3 in dry benzene, and a catalytic amount (2 wt %) of p-toluene-sulfonic acid were placed in a round-bottomed flask. The resulting solution is then heated at 50C for 3-4 hours, the reaction was complete, and the resulting solution was cooled to room temperature, and passed through a short pad of silicagel. The product obtained was crystallized from a mixture of hexane and dichloromethane. Yield: 90%.
  • 5. 2-(Cyclopentylethyl)-6-(3,4,5-trifluorophenyl)naphthalene (compound 5)
  • To a solution of compound 4 in ethyl acetate was added a catalytic amount (5 wt %) of 5% Pd—C, the resulting solution was continued stirring vigorously until the reaction was complete. The product obtained was crystallized from hexane. Yield 92%.
  • Incorporation of Deuterium into Structures:
  • Methods of incorporating one or more deuterium atoms into a structure are known in the art.
  • Characterization methods and property analysis of compounds and mixtures are well-known in the art. Methods to alter the material properties of a mixture, such as adding other compound to a mixture, or by adding more or less of a compound in a mixture, are also known in the art.
  • All references throughout this application, for example patent documents including issued or granted patents or equivalents; patent application publications; and non-patent literature documents or other source material; are hereby incorporated by reference herein in their entireties, as though individually incorporated by reference, to the extent each reference is at least partially not inconsistent with the disclosure in this application (for example, a reference that is partially inconsistent is incorporated by reference except for the partially inconsistent portion of the reference).
  • All patents and publications mentioned in the specification are indicative of the levels of skill of those skilled in the art to which the invention pertains. References cited herein are incorporated by reference herein in their entirety to indicate the state of the art, in some cases as of their filing date, and it is intended that this information can be employed herein, if needed, to exclude (for example, to disclaim) specific embodiments that are in the prior art. For example, when a compound is claimed, it should be understood that compounds known in the prior art, including certain compounds disclosed in the references disclosed herein (particularly in referenced patent documents), are not intended to be included in the claim and are intended to be able to be removed individually or collectively.
  • When a group of substituents is disclosed herein, it is understood that all individual members of those groups and all subgroups, including any isomers and enantiomers of the group members, and classes of compounds that can be formed using the substituents are disclosed separately. When a Markush group or other grouping is used herein, all individual members of the group and all combinations and subcombinations possible of the group are intended to be individually included in the disclosure.
  • Every formulation or combination of components described or exemplified can be used to practice the invention, unless otherwise stated. Specific names of compounds are intended to be exemplary, as it is known that one of ordinary skill in the art can name the same compounds differently. When a compound is described herein such that a particular isomer or enantiomer of the compound is not specified, for example, in a formula or in a chemical name, that description is intended to include each isomers and enantiomer of the compound described individual or in any combination. One of ordinary skill in the art will appreciate that methods, device elements, starting materials, synthetic methods, and mixture constituents other than those specifically exemplified can be employed in the practice of the invention without resort to undue experimentation. All art-known functional equivalents, of any such methods, device elements, starting materials, synthetic methods, and mixture constituents are intended to be included in this invention. Whenever a range is given in the specification, for example, a temperature range, a time range, or a composition range, all intermediate ranges and subranges, as well as all individual values included in the ranges given are intended to be included in the disclosure.
  • As used herein, “comprising” is synonymous with “including,” “containing,” or “characterized by,” and is inclusive or open-ended and does not exclude additional, unrecited elements or method steps. As used herein, “consisting of” excludes any element, step, or ingredient not specified in the claim element. As used herein, “consisting essentially of” does not exclude materials or steps that do not materially affect the basic and novel characteristics of the claim. Any recitation herein of the term “comprising”, particularly in a description of components of a composition or in a description of elements of a device, is understood to encompass those compositions and methods consisting essentially of and consisting of the recited components or elements. The invention illustratively described herein suitably may be practiced in the absence of any element or elements, limitation or limitations which is not specifically disclosed herein.
  • The terms and expressions which have been employed are used as terms of description and not of limitation, and there is no intention in the use of such terms and expressions of excluding any equivalents of the features shown and described or portions thereof, but it is recognized that various modifications are possible within the scope of the invention claimed. Thus, it should be understood that although the present invention has been specifically disclosed by preferred embodiments and optional features, modification and variation of the concepts herein disclosed may be resorted to by those skilled in the art, and that such modifications and variations are considered to be within the scope of this invention as defined by the appended claims.
  • In general the terms and phrases used herein have their art-recognized meaning, which can be found by reference to standard texts, journal references and contexts known to those skilled in the art. The definitions are provided to clarify their specific use in the context of the invention.
  • One skilled in the art would readily appreciate that the present invention is well adapted to carry out the objects and obtain the ends and advantages mentioned, as well as those inherent therein. The liquid crystal compounds and methods described herein as presently representative of preferred embodiments are exemplary and are not intended as limitations on the scope of the invention. Changes therein and other uses will occur to those skilled in the art, which are encompassed within the spirit of the invention, are defined by the scope of the claims.
  • Although the description herein contains many specificities, these should not be construed as limiting the scope of the invention, but as merely providing illustrations of some of the embodiments of the invention. Thus, additional embodiments are within the scope of the invention and within the claims. All references cited herein are hereby incorporated by reference to the extent that there is no inconsistency with the disclosure of this specification. Some references provided herein are incorporated by reference herein to provide details concerning additional starting materials, additional methods of synthesis, additional methods of analysis and additional uses of the invention.

Claims (17)

We claim:
1. A compound having the formula:
Figure US20150034872A1-20150205-C00025
wherein
R is selected from the group consisting of H and unsubstituted or substituted alkyl each having 1-12 carbon atoms wherein the substitutions are independently one or more of halogen or CN, wherein one or more —CH2— groups of the alkyl groups may independently be replaced with —O—, —S—, —CO—, —CO—O—, —O—CO—, —O—CO—O— or —CH═CH—, provided that heteroatoms are not connected directly, except as permitted in the listed groups;
A and B are each independently selected from the group consisting of: 1,4-cyclohexyl, in which one —CH2— or two not directly linked —CH2— can be replaced by O or S; 1,4-cyclohexenyl; piperidine-1,4-diyl; 1,4-bicyclo[2,2,2]octylene; 1,4-phenyl, which may be substituted with one or more halogens; Pyridin-5,2-dyl; pyrimidin-5,2-diyl; naphthalene-2,6-diyl; trans-decahydronaphthalene-2,6-diyl; tetrahydronaphthalene-2,6-diyl; indane; indene; phenanthryl; and dibenzofuran, which may each independently in each instance be independently substituted with one or more halogens and/or one or more X1-X4 substitutents;
Z1 is a single bond or C1-7 unsubstituted or substituted alkylene, wherein the substitutions are independently one or more of halogen or CN, wherein one or more —CH2— groups of the alkyl groups may each independently be replaced by —O—, —S—, —CO—O—, —O—CO—, —O—CO—O— or —CH═CH— provided that heteroatoms are not connected directly to each other except as permitted in the listed groups;
Z2 and Z3 are each independently selected from the group consisting of: a single bond, —(CH2)2—, —(CH2)4—, —CH═CHCH2CH2—, —CH2CH2CH═CH—, —CF2O—, —OCF2—, —CF2CF2—, —CF═CF—, —CH2CF2—, —CF2CH2—, —OCF2CF2O—, —C2H4CF2O—, —CH2CF2OCH2—, —CH2OCF2CH2—, —OCF2C2H4—, —C3H6O—, —CO3H6—, —C2H4OCH2—, —CH2OC2H4—, —CH2O—, —OCH2—, —CH═CH—, —C≡C—, and —COO—;
n, m and K are each independently 0, 1, or 2, and m+K+n≧2;
X1, X2, X3, and X4 are each independently selected from the group consisting of: H, F, Cl, CF3, CHF2, OCF3, OCF2H and CN;
Y is independently selected from the group consisting of: —H, —F, —Cl, —CN, —NCS, —OCHF2, —CHF2, —OCF3, —OCF2CF3, —CF3, C1-20 alkyl, C1-20 alkoxy, C1-20 alkenyl, and C1-20 alkenyloxy, wherein the alkyl, alkoxy, alkenyl, and alkenyloxy groups may be independently substituted by one or more halogens;
wherein one or more hydrogen atoms in Formula I may be replaced with deuterium;
provided that when R═H and Y has less than 2 carbon atoms and X3, X4 are H or when R═H and Y has two or more carbon atoms and Z1 has more than 3 carbon atoms, there must be a fused ring system present in the compound or one of Z1, Z2 and Z3 must be selected from the group consisting of: C1-C3 alkylene, —CH═CHCH2CH2—, —CH2CH2CH═CH—, —CF2O—, —OCF2—, —CF2CF2—, —CF═CF—, —CH2CF2—, —CF2CH2—, —OCF2CF2O—, —C2H4CF2O—, —CH2CF2OCH2—, —CH2OCF2CH2—, —OCF2C2H4—, —C3H6O—, —CO3H6—, —C2H4OCH2—, —CH2OC2H4—, and —CH═CH—;
and provided that when R is not H and Y does not contain a —CF2— group, either one of A and B is selected from the group consisting of: 1,4-cyclohexene, in which one or two not directly linked —CH2— groups are optionally replaced by —O— or —S—; Pyridin-5,2-diyl; pyrimidin-5,2-diyl; indane; indene; phenanthryl, and dibenzofuran; or one of Z1, Z2 and Z3 must be selected from the group consisting of: —(CH2)4—, —CH═CHCH2CH2—, —CH2CH2CH═CH—, —CF2O—, —OCF2—, —CF2CF2—, —CF═CF—, —CH2CF2—, —CF2CH2—, —OCF2CF2O—, —C2H4CF2O—, —CH2CF2OCH2—, —CH2OCF2CH2—, —OCF2C2H4—, —C3H6O—, —OC3H6—, —C2H4OCH2—, —CH2OC2H4—, —CH═CH—, and —C≡C—.
2. The compound of claim 1 having a positive dielectric constant.
3. The compound of claim 2, having formula I-1 through I-17 as shown herein.
4. The compound of claim 1 having a negative dielectric constant.
5. The compound of claim 4, having formula I-18 through I-47 as shown herein.
6. A liquid crystal mixture having positive dielectric constant comprising a compound of claim 1.
7. The mixture of claim 6, wherein the mixture further comprises at least one compound of formula II-XVI as shown herein.
8. The mixture of claim 6, wherein the mixture further comprises at least one compound of formula XVII-XXIII as shown herein.
9. The mixture of claim 6, wherein the mixture comprises at least one compound of formula II-XVI as shown herein and at least one compound of formula XVII-XXIII as shown herein.
10. A liquid crystal mixture having negative dielectric constant comprising a compound of claim 1.
11. The mixture of claim 10, wherein the mixture further comprises at least one compound of formula XXIV-XLIV as shown herein.
12. The mixture of claim 10, wherein the mixture further comprises at least one compound of formula XLV-XLVIII as shown herein.
13. The mixture of claim 10, wherein the mixture further comprises at least one compound of formula XXIV-XLIV as shown herein and at least one compound of formula XLV-XLVIII as shown herein.
14. A device comprising a compound of claim 1.
15. A device comprising a mixture of claim 4.
16. The compound of claim 1, wherein one or more hydrogen atoms in any ring is substituted with deuterium.
17. The compound of claim 1, wherein one or more hydrogen atoms in any non-ring structure is substituted with deuterium.
US14/456,743 2008-02-08 2014-08-11 Liquid crystals comprising cyclopentane groups Abandoned US20150034872A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US14/456,743 US20150034872A1 (en) 2008-02-08 2014-08-11 Liquid crystals comprising cyclopentane groups
US14/882,283 US9822303B2 (en) 2008-02-08 2015-10-13 Liquid crystals comprising cyclopentane groups
US15/817,634 US10745617B2 (en) 2008-02-08 2017-11-20 Liquid crystals comprising cyclopentane groups
US16/993,934 US20210122978A1 (en) 2008-02-08 2020-08-14 Liquid Crystals Comprising Cyclopentane Groups

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2723008P 2008-02-08 2008-02-08
PCT/US2009/033197 WO2009100204A1 (en) 2008-02-08 2009-02-05 Liquid crystals comprising cyclopentane groups
US86629510A 2010-12-17 2010-12-17
US14/456,743 US20150034872A1 (en) 2008-02-08 2014-08-11 Liquid crystals comprising cyclopentane groups

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US12/866,295 Continuation US8801966B2 (en) 2008-02-08 2009-02-05 Liquid crystals comprising cyclopentane groups
PCT/US2009/033197 Continuation WO2009100204A1 (en) 2008-02-08 2009-02-05 Liquid crystals comprising cyclopentane groups

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/882,283 Continuation US9822303B2 (en) 2008-02-08 2015-10-13 Liquid crystals comprising cyclopentane groups

Publications (1)

Publication Number Publication Date
US20150034872A1 true US20150034872A1 (en) 2015-02-05

Family

ID=40952455

Family Applications (5)

Application Number Title Priority Date Filing Date
US12/866,295 Active 2029-07-13 US8801966B2 (en) 2008-02-08 2009-02-05 Liquid crystals comprising cyclopentane groups
US14/456,743 Abandoned US20150034872A1 (en) 2008-02-08 2014-08-11 Liquid crystals comprising cyclopentane groups
US14/882,283 Active US9822303B2 (en) 2008-02-08 2015-10-13 Liquid crystals comprising cyclopentane groups
US15/817,634 Active US10745617B2 (en) 2008-02-08 2017-11-20 Liquid crystals comprising cyclopentane groups
US16/993,934 Abandoned US20210122978A1 (en) 2008-02-08 2020-08-14 Liquid Crystals Comprising Cyclopentane Groups

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12/866,295 Active 2029-07-13 US8801966B2 (en) 2008-02-08 2009-02-05 Liquid crystals comprising cyclopentane groups

Family Applications After (3)

Application Number Title Priority Date Filing Date
US14/882,283 Active US9822303B2 (en) 2008-02-08 2015-10-13 Liquid crystals comprising cyclopentane groups
US15/817,634 Active US10745617B2 (en) 2008-02-08 2017-11-20 Liquid crystals comprising cyclopentane groups
US16/993,934 Abandoned US20210122978A1 (en) 2008-02-08 2020-08-14 Liquid Crystals Comprising Cyclopentane Groups

Country Status (3)

Country Link
US (5) US8801966B2 (en)
CN (3) CN103320141A (en)
WO (1) WO2009100204A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9822303B2 (en) * 2008-02-08 2017-11-21 Vvi Bright China Ltd Liquid crystals comprising cyclopentane groups

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI462992B (en) * 2011-04-18 2014-12-01 Daxin Materials Corp Liquid crystal compound
CN102585840B (en) * 2011-12-23 2014-09-10 北京八亿时空液晶科技股份有限公司 Liquid crystal composition containing cyclopentyl compounds
GB201201511D0 (en) 2012-01-30 2012-03-14 Univ Leuven Kath Modified epitopes for boosting CD4+ T-cell responses
CN102924243B (en) * 2012-03-27 2013-11-06 石家庄诚志永华显示材料有限公司 Liquid crystal compound containing cyclopentyl and difluorometheneoxy linking group, preparation method and applications thereof
CN102746852A (en) * 2012-06-19 2012-10-24 深圳市华星光电技术有限公司 Liquid crystal molecule having five member ring
TW201414817A (en) * 2012-10-15 2014-04-16 Daxin Materials Corp Negative dielectric anisotropy liquid crystal compound and liquid crystal composition containing the same
CN103074073B (en) * 2012-12-20 2015-03-11 石家庄诚志永华显示材料有限公司 Negative dielectric anisotropic liquid crystal mixture
CN103254903B (en) * 2013-04-27 2016-04-06 石家庄诚志永华显示材料有限公司 Liquid crystalline cpd containing difluoro methylene key bridge and preparation method thereof and composition
CN103254912B (en) * 2013-05-30 2015-07-01 石家庄诚志永华显示材料有限公司 Nematic phase liquid crystal composition
CN103289709B (en) * 2013-06-04 2015-01-07 石家庄诚志永华显示材料有限公司 Quick-response nematic phase type liquid crystal composite
CN103289707B (en) * 2013-06-09 2015-07-01 石家庄诚志永华显示材料有限公司 Quick-response liquid crystal composition
CN103265959B (en) * 2013-06-09 2015-06-03 石家庄诚志永华显示材料有限公司 TFT (Thin Film Transistor) liquid crystal composite
CN103305232B (en) * 2013-06-14 2015-07-01 石家庄诚志永华显示材料有限公司 Nematic phase liquid crystal composition
CN103333698B (en) * 2013-06-28 2015-01-07 石家庄诚志永华显示材料有限公司 Difluoromethoxy ether-containing positive dielectric liquid crystal composition
CN103351878B (en) * 2013-07-09 2015-05-20 石家庄诚志永华显示材料有限公司 Liquid crystal composition containing cyclopentyl and difluoromethoxy ether compound
CN103351879B (en) * 2013-07-10 2015-04-08 石家庄诚志永华显示材料有限公司 Positive dielectric anisotropic liquid crystal composition
US9028714B2 (en) * 2013-08-30 2015-05-12 Shijiazhuang Chengzhi Yonghua Display Materials Co., Ltd. Liquid crystal compound preparation and application
CN103525429B (en) * 2013-08-30 2016-02-24 晶美晟光电材料(南京)有限公司 Liquid crystalline cpd, its preparation method, the liquid crystal compound comprising it and application
CN103509561B (en) * 2013-09-25 2015-09-09 石家庄诚志永华显示材料有限公司 A kind of positive dielectric anisotropy liquid crystal composition of quick response
CN103553873B (en) * 2013-10-31 2016-04-06 北京八亿时空液晶科技股份有限公司 A kind of cyclopentylidene cyclohexyl compounds and its preparation method and application
CN103614145B (en) * 2013-11-26 2015-06-24 北京八亿时空液晶科技股份有限公司 Tetrahydrofuran structure containing liquid crystal compound and preparation method and applications thereof
CN103756687B (en) * 2013-12-27 2015-11-25 北京八亿时空液晶科技股份有限公司 A kind of liquid-crystal composition and application thereof containing cyclopentyl and five fluorine propylene ether type monomer
CN103773384B (en) * 2014-01-27 2015-07-15 北京八亿时空液晶科技股份有限公司 Liquid crystal compound containing cyclopentyl and pentafluoro-allyloxy and liquid crystal composition thereof
CN104513666B (en) * 2014-10-10 2017-08-01 石家庄诚志永华显示材料有限公司 A kind of liquid crystal media and application
CN104479690A (en) * 2014-12-29 2015-04-01 石家庄诚志永华显示材料有限公司 Nematic phase liquid crystal composition
CN104513665A (en) * 2014-12-31 2015-04-15 石家庄诚志永华显示材料有限公司 Liquid crystal medium containing triphenyl series compounds and application thereof
CN104593004B (en) * 2015-02-15 2017-05-24 石家庄诚志永华显示材料有限公司 Liquid crystal composition
CN107557020A (en) * 2015-09-02 2018-01-09 石家庄诚志永华显示材料有限公司 A kind of liquid-crystal compounds and its preparation method and application
CN106883861B (en) * 2015-12-16 2019-04-19 北京八亿时空液晶科技股份有限公司 A kind of liquid-crystal compounds, composition and its application
KR102511837B1 (en) 2016-01-20 2023-03-20 삼성디스플레이 주식회사 Liquid crystal composition and liquid crystal display comprising the same
CN107286950A (en) * 2016-04-01 2017-10-24 北京八亿时空液晶科技股份有限公司 A kind of cyclopenta liquid-crystal compounds, composition and its application
CN107267156B (en) * 2016-04-07 2020-05-05 北京八亿时空液晶科技股份有限公司 Liquid crystal composition and application thereof
JP6866583B2 (en) * 2016-07-05 2021-04-28 Dic株式会社 Liquid crystal compound
CN107099304A (en) * 2017-05-09 2017-08-29 晶美晟光电材料(南京)有限公司 Liquid crystal compound and its application
CN109207160B (en) * 2017-07-03 2021-05-07 北京八亿时空液晶科技股份有限公司 Liquid crystal compound with negative dielectric anisotropy as well as preparation method and application thereof
TWI640501B (en) * 2017-09-29 2018-11-11 Daxin Materials Corporation Liquid crystal compound, liquid crystal composition and liquid crystal display device having thereof
CN107722997A (en) * 2017-10-31 2018-02-23 晶美晟光电材料(南京)有限公司 Liquid-crystal compounds, liquid crystal compound and its application of negative permittivity
CN107794054B (en) * 2017-10-31 2021-05-11 晶美晟光电材料(南京)有限公司 Liquid crystal compound, liquid crystal mixture and application thereof
CN108034433A (en) * 2017-11-17 2018-05-15 晶美晟光电材料(南京)有限公司 A kind of negative type liquid crystal mixture and its application
CN108384558A (en) * 2018-03-20 2018-08-10 晶美晟光电材料(南京)有限公司 A kind of negative type liquid crystal compound, the liquid crystal compound comprising the liquid-crystal compounds and its application
TWI660034B (en) * 2018-05-09 2019-05-21 達興材料股份有限公司 Liquid crystal composition and liquid crystal display device employing the same
CN108690640B (en) * 2018-07-17 2022-02-25 烟台显华化工科技有限公司 Compound containing indene ring and liquid crystal medium
CN111592889B (en) * 2019-02-20 2021-09-28 北京八亿时空液晶科技股份有限公司 Liquid crystal compound and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8801966B2 (en) * 2008-02-08 2014-08-12 Vvi Bright China Ltd. Liquid crystals comprising cyclopentane groups

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63179835A (en) 1986-12-20 1988-07-23 メルク・パテント・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング Cyclopentane derivative
US5271864A (en) 1992-08-07 1993-12-21 Displaytech, Inc. Ferroelectric liquid crystal compounds with cyclohexenyl cores and compositions containing them
JPH09227422A (en) * 1996-02-12 1997-09-02 Rolic Ag Cyclopentyl derivative
US5759443A (en) * 1996-07-26 1998-06-02 Rolic Ag Cyclopentyl derivatives
EP0821049B1 (en) 1996-07-26 2001-01-10 Rolic AG Cyclopentyl compounds
US6693223B1 (en) 1997-11-28 2004-02-17 Dainippon Ink And Chemicals, Inc. Fluorine-substituted-4-alkenylbenzoic acid and derivatives thereof, and nematic liquid crystal composition containing cyanophenyl benzoate derivatives and liquid crystal display system using the same
US6413448B1 (en) 1999-04-26 2002-07-02 Displaytech, Inc. Cyclohexyl- and cyclohexenyl-substituted liquid crystals with low birefringence
WO2001016131A2 (en) * 1999-09-01 2001-03-08 Clariant International Ltd Five membered-ring compounds and utilization thereof in liquid crystal mixtures
JP4449156B2 (en) * 2000-04-26 2010-04-14 チッソ株式会社 Cyclohexane derivative, liquid crystal composition containing the same, and liquid crystal display device
DE10135499A1 (en) 2001-07-20 2003-01-30 Merck Patent Gmbh Indane compounds with negative delta epsilon
AU2002314559A1 (en) 2001-08-02 2003-02-24 Fuji Photo Film Co., Ltd. Anthraquinone compound, liquid crystal composition, cell and display device employing the same
DE112004001265D2 (en) * 2003-08-22 2006-07-06 Merck Patent Gmbh Cyclopenta (a) naphthalene
CN100410346C (en) 2006-09-21 2008-08-13 青岛科技大学 Liquid crystal compound 4'-cyclopentyloxy-4-diphenylcarboxylic acid-3-fluoro-4-cyanobenzene ester and preparation method thereof
JP5712510B2 (en) 2010-06-18 2015-05-07 Jnc株式会社 Compound having 5-membered ring, liquid crystal composition, and liquid crystal display device
CN102924243B (en) 2012-03-27 2013-11-06 石家庄诚志永华显示材料有限公司 Liquid crystal compound containing cyclopentyl and difluorometheneoxy linking group, preparation method and applications thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8801966B2 (en) * 2008-02-08 2014-08-12 Vvi Bright China Ltd. Liquid crystals comprising cyclopentane groups

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9822303B2 (en) * 2008-02-08 2017-11-21 Vvi Bright China Ltd Liquid crystals comprising cyclopentane groups
US10745617B2 (en) 2008-02-08 2020-08-18 Vvi Bright China Ltd Liquid crystals comprising cyclopentane groups

Also Published As

Publication number Publication date
WO2009100204A1 (en) 2009-08-13
US10745617B2 (en) 2020-08-18
US20180163131A1 (en) 2018-06-14
CN101978024A (en) 2011-02-16
CN103320141A (en) 2013-09-25
US20210122978A1 (en) 2021-04-29
US8801966B2 (en) 2014-08-12
US20110089374A1 (en) 2011-04-21
CN101978024B (en) 2014-05-07
US9822303B2 (en) 2017-11-21
CN103319306A (en) 2013-09-25
US20160237348A1 (en) 2016-08-18

Similar Documents

Publication Publication Date Title
US10745617B2 (en) Liquid crystals comprising cyclopentane groups
JP6526990B2 (en) 4,6-Difluorodibenzofuran derivatives
JP6552254B2 (en) 4,6-difluorodibenzothiophene derivatives
JP4734579B2 (en) Difluoromethyl ether derivative and process for producing the same
JP4044618B2 (en) Fluorine-substituted benzene derivative, liquid crystal composition, and liquid crystal display device
TWI782041B (en) Dibenzofuran and dibenzothiophene derivatives
US6231785B1 (en) Benzene derivative and its production method
US8444877B2 (en) High dielectric constant liquid crystal
CA2381007A1 (en) Fused ring compound
JP4044617B2 (en) Liquid crystalline compound having negative dielectric anisotropy value, liquid crystal composition, and liquid crystal display device
CN109996791B (en) Monofluorinated cyclohexane
TWI787298B (en) Thioether derivatives of dibenzothiophene and dibenzofuran
US7708907B1 (en) Liquid crystal compounds and liquid crystal compositions comprising the same
JP4963863B2 (en) Novel compound and liquid crystal composition containing the compound
WO1997047576A1 (en) Fluorinated alkyl ether compounds, liquid-crystal compositions, and liquid-crystal display devices
JP2807670B2 (en) Propiolonitrile derivative, liquid crystal composition and liquid crystal display device
JP4304571B2 (en) Dihydronaphthalene derivative, liquid crystal composition containing the same, and liquid crystal display device
JP4042029B2 (en) Dihydronaphthalene derivative, liquid crystal composition containing the same, and liquid crystal display device
JP4478842B2 (en) Decahydronaphthalene derivative
TWI757383B (en) Thioether compounds
JP4844785B2 (en) Dihydronaphthalene derivative, liquid crystal composition containing the same, and liquid crystal display device
JP4042030B2 (en) Dihydronaphthalene derivative, liquid crystal composition containing the same, and liquid crystal display device
JP4042031B2 (en) Dihydronaphthalene derivative, liquid crystal composition containing the same, and liquid crystal display device
JP2006036719A (en) 2-naphthyl-1,3-dioxane derivative
JPH11349515A (en) 1,3-phenylene derivative

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: VVI BRIGHT, INC., COLORADO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CHEN, XINHUA;REDDY, R. AMARANATHA;REEL/FRAME:041966/0485

Effective date: 20101214

Owner name: VVI BRIGHT CHINA LTD, CHINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VVI BRIGHT, INC.;REEL/FRAME:041966/0581

Effective date: 20110309